期刊文献+

sEng与先兆子痫的研究进展 被引量:1

Research advances in sEng and preeclampsia
暂未订购
导出
摘要 先兆子痫是妊娠期特有的疾病,是孕产妇及围生儿死亡的重要原因之一。针对其发病原因,多年来国内外许多研究进行了各方面的探索,提出多种学说,但具体机制仍未明确。一种新的抗血管生成蛋白——可溶性endoglin(sEng)可能与先兆子痫的发病机制相关。文章就sEng的研究进展作一综述。 Preeclampsia is a unique syndrome during pregnancy, and is one of the important causes of maternal and perinatal death. Many domestic and foreign researches have been focusing on the pathogenesis of preeclampsia, and some theories have been proposed. However, its mechanism has not yet been clarified. It has been demonstrated by recent studies that a new anti-angiogenic protein, soluble endoglin (sEng) may be related to the pathogenesis of preeclampsia. This paper briefly introduces the research advances in relationship between sEng and preeclampsia.
作者 沈理 滕银成
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第4期474-476,共3页 Journal of Shanghai Jiao tong University:Medical Science
关键词 可溶性ENDOGLIN 先兆子痫 妊娠 soluble endoglin preeclampsia pregnancy
  • 相关文献

参考文献16

  • 1Sibai B, Dekker G, Kupfermine M. Pre-eelampsia [ J ]. Lancet, 2005,365 (9461): 785-799.
  • 2Agrotis A, Kalinina N, Bobik A. Transforming growth factor-beta, cell signaling and cardiovascular disorders [ J ]. Curr Vasc Pharmacol, 2005, 3 ( 1 ) :55 -61.
  • 3Wikst rom P, Lissbrant IF, Stattin P, et al . Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer[ J ]. Prostate, 2002, 51 (4) :268 - 275.
  • 4Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia [ J ]. Nat Med, 2006, 12(6) :642 -649.
  • 5Napolitano M, Miceli F, Calce A, et al. Expression and relationship between endothelial messenger ribonucleic acid and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas[J].J Clin Endocrinol Metab, 2000, 85(6) : 2318 - 2323.
  • 6Staff AC, Braekke K, Johnsen GM, et al. Circulating concentrations of soluble endoglin (CDI05) in fetal and maternal serum and in amniotic fluid in preeclampsia[ J]. Am J Obstet Gynecol, 2007, 197(2) :176. e1 -176. e6.
  • 7Levine RJ, Lain C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia [ J ]. N Engl J Med, 2006,355(10) :992 - 1005.
  • 8Stepan H, Geide A, Faber R. Soluble fms-like tyrosine kinase 1 [J]. N EnglJ Med, 2004,351( 21): 2241 -2242.
  • 9Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia [ J ]. Microvasc Res ,2007, 75 ( 1 ) : 1 - 8.
  • 10Robinson CJ, Johnson DD. Soluble endoglin as a second-trimester marker for preeclampsia[ J ]. Am J Obstet Gynecol, 2007,197 (2) : 174. el -175. el

同被引文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部